MTLS | tickerfilter.com

Fundamental analysis

15%

Profitability 0%

Dept financing 24%

Liquidity 46%

Performance 20%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-2.46%

1 Month

4.88%

3 Months

-39.79%

6 Months

-16.37%

1 Year

-3.55%

2 Year

-44.69%

Key data

Stock price

$5.16

P/E Ratio

0.00

DAY RANGE

$5.09 - $5.25

EPS

-$0.07

52 WEEK RANGE

$3.93 - $9.69

52 WEEK CHANGE

-$1.15

MARKET CAP

316.009 M

YIELD

N/A

SHARES OUTSTANDING

59.067 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-24-2025

BETA

1.02

PUBLIC FLOAT

AVERAGE 10 VOLUME

$172,469

AVERAGE 30 VOLUME

$230,738

Company detail

CEO: Wilfried Vancraen
Region: US
Website: materialise.com
Employees: 2,330
IPO year: 2014

Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services

Materialise NV provides additive manufacturing and medical software, and 3D printing services. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Materialise has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.

MTLS - MATERIALISE NV